WHO ICTRP trial
A study to understand the effect of Ticagrelor, an oral antiplatelet medication…
CTRI/2025/06/089010 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/06/089010 |
|---|---|
| Public title | A study to understand the effect of Ticagrelor, an oral antiplatelet medication that helps prevent blood clots in Indian patients with Acute Coronary Syndrome |
| Scientific title | A Real-World Retrospective Study to evaluate Effectiveness and Tolerability of Ticagrelor in Indian patients with Acute Coronary SyndRome (STAR Study) |
| Primary sponsor | Sun Pharma Laboratories Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: I20-I25- Ischemic heart diseases |
| Interventions | Intervention1: Nil: Nil Control Intervention1: Nil: Nil |
| Registration date | Jun 17, 2025 |
| Target size | 5000 |
| Secondary IDs | SP/CVD/STAR/02-2025 Version 1.0 dated 22.05.2025 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: